职业性接触铂类抗肿瘤药物工人的血象观察
摘要
铂类药物由于在肿瘤治疗方面效果显著,被广泛应用于临床,成为许多肿瘤联合用药方案中的重要组成部分,但是,铂类药物存在一定的毒性,可能对接触者的血液系统产生影响,为此,我们于2011年4月对鞍山市某制药厂接触铂类抗肿瘤药物的工人进行了职业性健康检查,现将结果报告如下。
出处
《中国冶金工业医学杂志》
2012年第3期320-321,共2页
Chinese Medical Journal of Metallurgical industry
二级参考文献13
-
1Wood PA, Hrushesky WJ. Cisplatin -associated anemia: an erythropoietin deficiency syndrome[J]. J Clin Invest, 1995,95 (4): 1650 - 1659.
-
2Schuster SJ, Koury ST, Bohrer M,et al. Cellular sites of extrarenal and renal erythropoietin production in anaemic rats [ J ]. Br J Haematol, 1992,81 (2) :153 - 159.
-
3Leibbrandt ME, Wolfgang GH, Metz AL,et al. Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells [ J ]. Kidney Int, 1995,48 ( 3 ) :761 - 770.
-
4Smith DH, Goldwasser E, Vokes EE. Serum immunoerythropoietin levels in patients with cancer receiving cisplatin - based chemotherapy[J]. Cancer,1991,68(5) :1101 - 1105.
-
5Belenkov AI, Shenouda G, Rizhevskaya E, et al . Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin[J]. Mol Cancer Ther,2004,3(12) :1525 - 1532.
-
6Grote T, Yeilding AL, Castillo R, et al. Efficacy and safety analysis of epoetin alfa in patients with small - cell lung cancer: a randomized, double - blind, placebo - controlled trial[J]. J Clin Oncol, 2005,23 (36) :9377 - 9386.
-
7Leyland -Jones B, Semiglazov V, Pawlicki M, et al . Maintaining normal epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first - line chemotherapy: a survival study[J]. J Clin Oncol,2005,23 ( 25 ) :5960 - 5972.
-
8Henke M, Laszig R, Rube C,et al . Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double - blind, placebo - controlled trial[ J ]. Lancet,2003,362(9392) : 1255 - 1260.
-
9Ludwig H, Van Belle S, Barrett - Lee P, et al . The European Cancer Anaemia Survey (ECAS) : a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients[J]. Eur J Cancer,2004 ,40(15) : 2293 ~ 2306.
-
10Caro JJ, Salas M, Ward A,et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review[J]. Cancer,2001,91 (12) :2214-2221.
-
1崔伟,刘培良,马俊芳.某制药厂铂类抗肿瘤药制造工人的血象观察[J].中华劳动卫生职业病杂志,2010,28(3):185-185.
-
2尹虹,徐雪琴,林丽玉,胡显玲,唐少华,陆叶珍,李晓雪,何继亮.职业性接触抗肿瘤药物护士DNA损伤的情况[J].中华劳动卫生职业病杂志,2010,28(3):218-219. 被引量:1
-
3江会,李武平,董建英.国外职业性接触抗肿瘤药物的研究和防护对我国的启示[J].护理管理杂志,2004,4(12):22-24. 被引量:45
-
4胡传来,杨永坚.接触抗癌药对护士妊娠经过及妊娠结局的影响[J].中华预防医学杂志,1999,33(3):174-174. 被引量:1
-
5徐春艳,康霞,安慧艳.静脉药物配置中心护理人员的职业防护[J].中国冶金工业医学杂志,2012,29(5):599-599. 被引量:1
-
6金力奋,何继亮,张美辩.抗肿瘤药接触对护士的遗传损伤[J].环境与健康杂志,2003,20(1):21-22. 被引量:18
-
7张春华,佟建冬.无机砷对机体损害的研究进展[J].中国实用医药,2007,2(36):165-167. 被引量:5
-
8胡传来,杨永坚,赵存喜,余秋月.临床护士自然流产危险因素[J].疾病控制杂志,2000,4(4):341-342. 被引量:4
-
9刘敏.化疗药物配制及静脉输注的防护[J].中国医药指南,2013,11(30):593-594.
-
10杨东平,徐世杰,王建新.职业接触抗癌药物护士外周血淋巴细胞DNA损伤的研究[J].中华劳动卫生职业病杂志,2002,20(3):197-199. 被引量:6